Yes. Dendritic cells serve as a critical bridge between innate and adaptive immunity, and their quantity and function can reflect immune activity and antigen presentation capacity.

Different dendritic cell subsets perform distinct roles in immune regulation, including antigen recognition, anti-tumor immunity, antiviral responses, and immune modulation.

Abnormal dendritic cell counts or functions may be associated with infections, chronic inflammation, tumor immune evasion, autoimmune diseases, or immune aging. Clinical evaluation is recommended for interpretation.

Yes. Certain medications, including immunosuppressants, corticosteroids, chemotherapy, and immunotherapy treatments, may influence the results. Please inform your physician about any current medications before testing.

Follow-up testing every 3–6 months is recommended to monitor immune status, treatment response, and disease progression.

This test is recommended for cancer patients, individuals with chronic infections, patients receiving vaccines or immunotherapy, and anyone interested in understanding their immune health and disease risk.